Giannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG
Analysts now predict that the GLP-1 market could reach $71 billion by 2032, driven by increasing demand for these medications in the treatment of obesity, type 2 diabetes, and cardiovascular conditions
Lillys strong R&D capabilities, clinical success in obesity and diabetes care, and substantial investments in manufacturing capacity position it as one of the most influential players driving growth in the GLP-1 market globally
If done right, fruit-based desserts can give you a natural boost of fiber, antioxidants, and just enough sweetness
Research on esophagogastric anastomosis healing further demonstrated the peptides capabilities
High-concentration glutathione (moisturizing ingredient) instantly brightens skin tone